Menopause cardiovascular risk assessment in Delaware
Comprehensive cardiovascular risk review for midlife women in Delaware.
What we assess
ApoB, Lp(a), fasting lipids, hs-CRP, blood pressure, HbA1c, and family history.
Why timing matters
The 10-year window after menopause is critical for prevention.
Getting started
Book a Kindr visit from Delaware.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.